Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival

Accumulating evidence suggests the roles of glutamate metabotropic receptors (GRMs) in cancer, in addition to synaptic signalling. The present study assessed the associations of genetic variants in eight GRM genes with regard to risk and overall survival (OS) in 780 renal cell carcinoma (RCC) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chao‐Yuan, Hsueh, Yu‐Mei, Chen, Lih‐Chyang, Cheng, Wei‐Chung, Yu, Chia‐Cheng, Chen, Wei‐Jen, Lu, Te‐Ling, Lan, Kuo‐Jin, Lee, Cheng‐Hsueh, Huang, Shu‐Pin, Bao, Bo‐Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308098/
https://www.ncbi.nlm.nih.gov/pubmed/30488581
http://dx.doi.org/10.1002/cam4.1901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308098/
https://www.ncbi.nlm.nih.gov/pubmed/30488581
http://dx.doi.org/10.1002/cam4.1901

Ejemplares similares